News & Events

You are here

Presenting at this year’s Accelerating Clinical Trials in Asia 2017, Novotech CRO Executive Director Dr Yooni Kim presented an overview of recent regulatory change in Asia and discussed its resulting impact on clinical trial management and patient recruitment. 

19/07/17

Novotech launches new site management organisation (SMO) business in South Korea

19 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include clinical trial site management organisation (SMO)...

19/07/17

노보텍, 임상시험실시지원기관노보텍SMO 설립

2017 719 호주시드니대한민국서울:  ...

29/06/17

Novotech receives ISO 9001:2015 certification

29 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has received ISO 9001:2015 Quality Management System certification for its corporate headquarters in Sydney, Australia.

...

19/06/17

Novotech signs central lab services agreement with Sonic Clinical Trials

19 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an...

13/06/17

Novotech Update: Five things you need to know about China’s changing clinical trial environment

Novotech Update: New policy reforms in China focus on reducing clinical trial start up times and improving site access 

China currently has one of the largest...

15/04/17

Novotech signs MOU with South Korea’s leading medical center, the Asan Medical Center

15 April 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea’s largest medical institution – The Asan Medical Center’s...

01/03/17

New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials

 

1 March 2017, Sydney, Australia: Frost & Sullivan today released its latest white paper, ‘Asia: Preferred Destination for Clinical Trials’, with Asia Pacific specialist CRO Novotech. Research...

27/01/17

Novotech Update: 8 reasons why China should be your next clinical trial destination

Happy Chinese New Year!
While China has long been a key powerhouse in Asia, its trajectory over the next decade is set to sky rocket. 

Here are 8 top facts you need to know about China’s growing economy and...

27/01/17

Novotech Update: 8 reasons why Australia should be your next clinical trial destination

Australia is internationally recognised for its superior clinical research and healthcare infrastructure, world-class research capabilities and highly killed researchers. All critical prerequisites for early phase clinical trials...

16/01/17

Novotech Update: Novotech and Deloitte brief biotech companies on benefits of accessing Australia’s R&D scheme

 

10 January 2017; San Francisco, California, United States: At a private event during this year’s JP Morgan conference, Novotech and Deloitte briefed international biotech companies on how to access...

Pages